TY - JOUR
T1 - An initial review of residual symptoms after empirically supported trauma-focused cognitive behavioral psychological treatment
AU - Larsen, Sadie E.
AU - Bellmore, Aimee
AU - Gobin, Robyn L.
AU - Holens, Pamela
AU - Lawrence, Karen A.
AU - Pacella-LaBarbara, Maria L.
N1 - Publisher Copyright:
© 2019
PY - 2019/4
Y1 - 2019/4
N2 - Objective: Although residual symptoms remain following clinical treatment for posttraumatic stress disorder (PTSD), little is known about the characteristics of these residual symptoms. We aimed to determine the type, severity, and frequency of symptoms that remain after trauma-focused psychotherapy. Methods: We conducted a systematic review of 51 randomized controlled trials of empirically supported psychosocial interventions for PTSD (68 total treatment arms). Outcomes included: 1) PTSD symptoms and 2) conditions commonly comorbid with PTSD: depression, anxiety, and quality of life impairment. Results: In general, the results revealed that participants who completed PTSD treatment continued to report residual PTSD symptoms: 31% reported clinical symptom levels, and 59% reported subthreshold levels at posttreatment, particularly within the hyperarousal cluster. Residual symptoms also emerged for depression (19% clinical), anxiety (55% clinical), and quality of life (36% clinical). Few differences emerged across treatment types, but differential patterns were revealed for sample/trauma types. Conclusions: Results suggest a need for focused research attention to and clinical assessment of individual residual symptoms following empirically supported treatment for PTSD to determine whether further treatment sessions are warranted.
AB - Objective: Although residual symptoms remain following clinical treatment for posttraumatic stress disorder (PTSD), little is known about the characteristics of these residual symptoms. We aimed to determine the type, severity, and frequency of symptoms that remain after trauma-focused psychotherapy. Methods: We conducted a systematic review of 51 randomized controlled trials of empirically supported psychosocial interventions for PTSD (68 total treatment arms). Outcomes included: 1) PTSD symptoms and 2) conditions commonly comorbid with PTSD: depression, anxiety, and quality of life impairment. Results: In general, the results revealed that participants who completed PTSD treatment continued to report residual PTSD symptoms: 31% reported clinical symptom levels, and 59% reported subthreshold levels at posttreatment, particularly within the hyperarousal cluster. Residual symptoms also emerged for depression (19% clinical), anxiety (55% clinical), and quality of life (36% clinical). Few differences emerged across treatment types, but differential patterns were revealed for sample/trauma types. Conclusions: Results suggest a need for focused research attention to and clinical assessment of individual residual symptoms following empirically supported treatment for PTSD to determine whether further treatment sessions are warranted.
KW - Cognitive behavioral therapy
KW - PTSD
KW - Posttraumatic stress disorder
KW - Refractory symptoms
KW - Residual symptoms
UR - http://www.scopus.com/inward/record.url?scp=85062017564&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85062017564&partnerID=8YFLogxK
U2 - 10.1016/j.janxdis.2019.01.008
DO - 10.1016/j.janxdis.2019.01.008
M3 - Review article
C2 - 30825720
AN - SCOPUS:85062017564
SN - 0887-6185
VL - 63
SP - 26
EP - 35
JO - Journal of Anxiety Disorders
JF - Journal of Anxiety Disorders
ER -